e, a neurological disease, as well as cardiovascular disease, was evaluated and it was found that genetic information combined with personal health status affected levels of anxiety, as well as further short-term depletion of risk factors for cardiovascular disease. It was discovered that patients with neurological impairments or manifesting Huntington disease symptoms experienced depression at a higher level, and a lower level of quality of life. Conflicting results were found pertaining to cancer. One study reported that there were no levels of distress and anxiety based on the presence or absence of a disease within the family history. However, another two studies found higher levels of distress in people who have already experienced a diagnosis or a cancer. Coping strategies were enacted more by women with a personal cancer history more than women without experience with cancer. Receiving results increased the cognizance of risk, as well as increased screenings and checkups. These studies assisted in understanding how psycho-behavioral reactions could lead to better ways of organizing personal care plans (Oliveri, Ferrari, Manfrinati, Pravettoni, 2018). The research done for the genetic testing of cardiovascular disease, neurodegenerative diseases and cancer allows researchers to better understand how users’ perceptions of developing these diseases affect their lifestyle and psychological well-being. The studies allowed researchers to explore how the application of genetic testing can affect how personal care plans are organized, as well as influence patients in their lifestyle and choosing appropriate situations for their health. Cancer affects the human body in many ways. The cardiovascular and nervous system are both heavily affected by cancer. They are both extremely important systems in the human body and are susceptible to diseases, such as Alzheimer’s disease for the nervous system and cardiovascular disease for the cardiovascular system. Cancer survivors are at a higher risk of cardiovascular morbidity and mortality that is disease related (Adams, Schondorf, Benoit, Kilgour, 2015). The treatments for cancer can affect the body as well. Antibodies, such as trastuzumab, can be related to cardiomyopathy in breast cancer patients when it is used with additive and helpful chemotherapy (Jancin, 2008). A leading cause of morbidity and mortality in cancer survivors has become chemotherapy related cardiotoxicity (Pradeep, et al., 2018).